Several exciting updates from the last few weeks.
Proterra leads the way, with coverage in Forbes – and with press on three recent deals: (1) 15 new buses funded by the San Joaquin Valley Air Pollution Control District; (2) in the Chicago Tribune of an announcement in late October about a partnership with JLL to deliver 10 Catalyst buses for a service operating between Chicago’s commuter train stations the Prudential Plaza and Aon Center, both JLL-managed properties, in Chicago; and (3) the Pioneer Valley Transit Authority in Massachusetts.
Target Pharma continues to outperform, announcing its fourth disease community in partnership with Bristol-Myers Squibb – following its earlier announcement in partnership with Intercept Pharmaceuticals.
KIYATEC is not far behind – moving by popular acclaim from a startup to a breakout success. Keep up the good work.
Pharmright is accelerating nationally – demo’ing the Livi from Missouri to Maine.
Avadim announced its recognition by Vizient for the innovation of its technology and its plans to make $3.1 million of products per week at its new facility.
And lastly Crowdr provided a sneak peak of its mobile app Booster that launches in January. See you on there!